These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 19444979)

  • 1. The use of combination FEIBA and rFVIIa bypassing therapy, with TEG profiling, in uncontrollable bleeding associated with acquired haemophilia A.
    Dunkley SM; Yang K
    Haemophilia; 2009 May; 15(3):828-30. PubMed ID: 19444979
    [No Abstract]   [Full Text] [Related]  

  • 2. Sequential therapy with activated prothrombin complex concentrate (FEIBA) and recombinant factor VIIa in a patient with severe haemophilia A, inhibitor presence and refractory bleeding.
    Economou M; Teli A; Tzantzaroudi A; Tsatra I; Zavitsanakis A; Athanassiou-Metaxa M
    Haemophilia; 2008 Mar; 14(2):390-1. PubMed ID: 18194305
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost minimization analysis to compare activated prothrombin complex concentrate (APCC) and recombinant factor VIIa for haemophilia patients with inhibitors undergoing major orthopaedic surgeries.
    Bonnet PO; Yoon BS; Wong WY; Boswell K; Ewenstein BM
    Haemophilia; 2009 Sep; 15(5):1083-9. PubMed ID: 19456876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant infusion of low doses of rFVIIa and FEIBA in haemophilia patients with inhibitors.
    Martinowitz U; Livnat T; Zivelin A; Kenet G
    Haemophilia; 2009 Jul; 15(4):904-10. PubMed ID: 19473416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FEIBA in the treatment of acquired haemophilia A: results from the prospective multicentre French 'FEIBA dans l'hémophilie A acquise' (FEIBHAC) registry.
    Borg JY; Négrier C; Durieu I; Dolimier E; Masquelier AM; Lévesque H;
    Haemophilia; 2015 May; 21(3):330-337. PubMed ID: 25359571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From theory to practice: applying current clinical knowledge and treatment strategies to the care of hemophilia a patients with inhibitors.
    Gomperts ED; Astermark J; Gringeri A; Teitel J
    Blood Rev; 2008 Feb; 22 Suppl 1():S1-11. PubMed ID: 18485996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of tolerance after combined immunosuppression and -adsorption in two patients with acquired haemophilia after severe haemorrhages controlled by sequential administration of rFVIIa and FEIBA.
    Stockschläder M; Ruf L; Linderer A; Schroeder T; Knoefel WT; Haas R; Giers G; Gerhardt A; Sucker C; Zotz RB; Scharf RE
    Thromb Haemost; 2009 Mar; 101(3):586-90. PubMed ID: 19277426
    [No Abstract]   [Full Text] [Related]  

  • 8. Commentary on Knight et al.: A systematic review of the cost-effectiveness of rFVIIa and APCC in the treatment of minor/moderate bleeding episodes for haemophilia patients with inhibitors.
    Hay JW; Zhou ZY
    Haemophilia; 2010 Mar; 16(2):366-8; discussion 369-71. PubMed ID: 19811544
    [No Abstract]   [Full Text] [Related]  

  • 9. Activated prothrombin complex concentrate for acquired haemophilia when recombinant factor VIIa fails.
    Hussein Z; Kudva GC; Reimers HJ
    Haemophilia; 2009 May; 15(3):831-2. PubMed ID: 19175418
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanisms and monitoring of bypassing agent therapy.
    Hoffman M; Dargaud Y
    J Thromb Haemost; 2012 Aug; 10(8):1478-85. PubMed ID: 22632160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical interventions in a cohort of patients with haemophilia A and inhibitors: an experiential retrospective chart review.
    Kraut EH; Aledort LM; Arkin S; Stine KC; Wong WY
    Haemophilia; 2007 Sep; 13(5):508-17. PubMed ID: 17880437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo haemostatic effects of activated prothrombin complex concentrate and recombinant factor VIIa in a haemophilia A patient with inhibitors.
    Grossmann R; Geisen U; Walter U
    Haemophilia; 2001 Nov; 7(6):589-91. PubMed ID: 11851758
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluating and monitoring the efficacy of recombinant activated factor VIIa in patients with haemophilia and inhibitors.
    Qi X; Zhao Y; Li K; Fan L; Hua B
    Blood Coagul Fibrinolysis; 2014 Oct; 25(7):754-60. PubMed ID: 24806320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of factor VIII inhibitor bypassing activity (FEIBA), recombinant factor VIIa or both on thrombin generation in normal and haemophilia A plasma.
    Livnat T; Martinowitz U; Zivelin A; Seligsohn U
    Haemophilia; 2008 Jul; 14(4):782-6. PubMed ID: 18371162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential response to bypassing agents complicates treatment in patients with haemophilia and inhibitors.
    Berntorp E
    Haemophilia; 2009 Jan; 15(1):3-10. PubMed ID: 19016901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic treatment with FEIBA of a haemophilia A patient with inhibitor: what are the costs, what are the benefits?
    Siegmund B; Richter H; Pollmann H
    Haemophilia; 2005 Nov; 11(6):638-41. PubMed ID: 16236116
    [No Abstract]   [Full Text] [Related]  

  • 17. Combination of FVIII and low-dose rFVIIa improves haemostasis in acquired haemophilia A patients: a collaborative controlled study.
    Zhang XH; Zhu XL; Niu T; Sun J; Liu H; Feng R; Yang LH; Wei Q; Ma QH; Wang QM; Feng FE; Fu HX; Mo XD; Lv M; Huang XJ
    Thromb Res; 2015 May; 135(5):835-40. PubMed ID: 25747536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single 270 microg kg(-1)-dose rFVIIa vs. standard 90 microg kg(-1)-dose rFVIIa and APCC for home treatment of joint bleeds in haemophilia patients with inhibitors: a randomized comparison.
    Young G; Shafer FE; Rojas P; Seremetis S
    Haemophilia; 2008 Mar; 14(2):287-94. PubMed ID: 18081834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgery in haemophilia patients with inhibitors, with special emphasis on orthopaedics: Madrid experience.
    Rodriguez-Merchan EC; Jimenez-Yuste V; Gomez-Cardero P; Alvarez-Roman M; Martin-Salces M; Rodriguez de la Rua A
    Haemophilia; 2010 May; 16(102):84-8. PubMed ID: 20536990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylaxis in haemophilia with inhibitors: update from international experience.
    Carcao M; Lambert T
    Haemophilia; 2010 Mar; 16 Suppl 2():16-23. PubMed ID: 20132334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.